Novome Biotechnologies: Funding, Investors & Team (Oct 2026)
Novome Biotechnologies, Inc. is a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The Company has developed the first-ever platform for controlled colonization of the gut with engineered bacteria, enabling first-in-class living therapeutics: Genetically Engineered Microbial Medicines (GEMMs). Novome is utilizing its proprietary GEMMs platform in its lead preclinical program in hyperoxaluria, which is focused on the development of a therapeutic strain of bacteria that degrades oxalate to prevent the formation of kidney stones. Efforts are also directed to the expansion of its proprietary synthetic biology platform into additional indications.
Novome Biotechnologies has raised $43.5M across 1 funding round on record, the most recent a Series B of $43.5M announced in Sep 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Novome Biotechnologies Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Novome Biotechnologies Funding Rounds
Novome Biotechnologies Founders and Leadership Team
Contact details for the Novome Biotechnologies team: 1 of 1 has an email address on file.
Start 14-day free trial →Novome Biotechnologies Funding Compared to Other Biotechnology Startups
Novome Biotechnologies' latest round of $43.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Novome Biotechnologies in Biotechnology and South San Francisco
Companies Similar to Novome Biotechnologies
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Novome Biotechnologies Funding FAQs
What does Novome Biotechnologies do?
Novome Biotechnologies, Inc. is a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The Company has developed the first-ever platform for controlled colonization of the gut with engineered bacteria, enabling first-in-class living therapeutics: Genetically Engineered Microbial Medicines (GEMMs). Novome is utilizing its proprietary GEMMs platform in its lead preclinical program in hyperoxaluria, which is focused on the development of a therapeutic strain of bacteria that degrades oxalate to prevent the formation of kidney stones. Efforts are also directed to the expansion of its proprietary synthetic biology platform into additional indications.
How much funding has Novome Biotechnologies raised?
Novome Biotechnologies has raised $43.5M across 1 round on record. The most recent is a Series B of $43.5M announced in Sep 2022.
When did Novome Biotechnologies last raise funding?
Novome Biotechnologies' most recent funding round on record is a Series B of $43.5M, announced in Sep 2022.
Who founded Novome Biotechnologies?
FundedIQ lists Zachary Russ (Founder) at Novome Biotechnologies.
Where is Novome Biotechnologies headquartered?
Novome Biotechnologies is based in South San Francisco, California, United States.
How many employees does Novome Biotechnologies have?
Novome Biotechnologies is in the 11-50 employee band.
How does Novome Biotechnologies' funding compare to other Biotechnology startups?
Novome Biotechnologies' latest round of $43.5M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Novome Biotechnologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Novome Biotechnologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.